Angiotech Pharmaceuticals CEO and leadership

John R. Barr has served as our President and Chief Executive Officer since June 2008 and, prior to that, served as our Chief Operating Officer since September 2005. Prior to joining our company, Mr. Barr served as President and Chief Executive Officer of V.I. Technologies prior to its merger with Panacos Pharmaceuticals in 2005. Prior to joining V.I. Technologies, Mr. Barr served from June 1990 to November 1997 as President of North American Operations for Haemonetics Corporation, a leading medical device manufacturer, and from July 1981 to April 1990 in both financial and operational roles for Baxter Healthcare. Mr. Barr holds a Master's Degree in management from the J.L. Kellogg Graduate School of Management and a Bachelor of Science Degree in bioengineering from the University of Pennsylvania.

Rui Avelar is an Head of Research & Development and Chief Medical Officer at EVOLUS INC, Physician at Vancouver Canucks, and Chief Medical Officer at ANGIOTECH PHARMACEUTICALS INC and is based in Newport Beach, California. He has worked as Rui Avelar, MD,CCFP, DIP SPORTS MED at Sports Medicine, Private Practice; Team Physician at Vancouver Canucks, Orca Bay Sports & Enterainment; and Chief Medical Officer, Vice President at ALLERGAN. Rui works or has worked as MEMBER at ACADEMY OF SPORTS MEDICINE, Lecturer at East Carolina University, and Physician at Lithuanian Alliance of America. He studied at University of Toronto between 1985 and 1989.

Victor Diaz is a President and Chief Operating Officer at ANGIOTECH PHARMACEUTICALS INC and is based in Libertyville, Illinois. He has worked as VP Manufacturing at Covidien (Medtronic Minimally Invasive Therapies Group), VP:Manufacturing at Medtronic, and Senior VP:Global Manufacturing at ANGIOTECH PHARMACEUTICALS INC. Victor works or has worked as VP:Manufacturing at Kendall Healthcare Products. He studied at Universidad Autónoma de Baja California between 1979 and 1983.